Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT01385657 · COMPLETED
Trial details
- NCT number
- NCT01385657
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-31
- Primary completion
- 2012-03-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.